The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
about
How to Define the Latent Reservoir: Tools of the TradeChallenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV ReservoirsHIV-1 functional cure: will the dream come true?Multi-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque ControllersPerspectives for immunotherapy: which applications might achieve an HIV functional cure?Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory AgentsAchieving HIV-1 Control through RNA-Directed Gene RegulationLatency reversal and viral clearance to cure HIV-1.Romidepsin-induced HIV-1 viremia during effective ART contains identical viral sequences with few deleterious mutations.Advancements in Developing Strategies for Sterilizing and Functional HIV Cures.The Human Immunodeficiency Virus 1 ASP RNA promotes viral latency by recruiting the Polycomb Repressor Complex 2 and promoting nucleosome assemblyModeling the Effects of Vorinostat In Vivo Reveals both Transient and Delayed HIV Transcriptional Activation and Minimal Killing of Latently Infected Cells.Human Galectin-9 Is a Potent Mediator of HIV Transcription and ReactivationTargeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems.The effect of Ingenol-B on the suppressive capacity of elite suppressor HIV-specific CD8+ T cells.Recent developments in the effort to cure HIV infection: going beyond N = 1.In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors.Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1.Development of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individualsGnidimacrin, a Potent Anti-HIV Diterpene, Can Eliminate Latent HIV-1 Ex Vivo by Activation of Protein Kinase C β.Elevated Plasma Viral Loads in Romidepsin-Treated Simian Immunodeficiency Virus-Infected Rhesus Macaques on Suppressive Combination Antiretroviral Therapy.Novel Assays for Measurement of Total Cell-Associated HIV-1 DNA and RNA.The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb.The Effect of Latency Reversal Agents on Primary CD8+ T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication.The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell functionActivation of HIV-1 expression in latently infected CD4+ T cells by the small molecule PKC412.HIV-1 Latency and Eradication: Past, Present and FutureDesign and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.When to start paediatric testing of the adult HIV cure research agenda?Why cure, why now?HIV-1 Reservoirs During Suppressive Therapy.International AIDS Society global scientific strategy: towards an HIV cure 2016.Multiple Origins of Virus Persistence during Natural Control of HIV Infection.HIV-1 Eradication: Early Trials (and Tribulations).Perspectives on Human Immunodeficiency Virus (HIV) Cure: HIV Persistence in Tissue.New challenges in therapeutic vaccines against HIV infection.Regulation of the Coxsackie and adenovirus receptor expression is dependent on cystic fibrosis transmembrane regulator in airway epithelial cells.Paediatric HIV infection: the potential for cure.Kill: boosting HIV-specific immune responses.
P2860
Q26766705-AB26AE4D-DFF3-4381-851C-633A55D7B1B3Q26781511-0C948664-567E-4738-A6F4-7C7C7A7A484AQ26865803-17A91DC0-8A72-41A1-AB53-AFCD25A5C8F2Q27312050-8849F0D8-A019-482D-B5C8-4C81EA183A65Q28078726-3178BC5D-C566-4139-9B0E-8A5A19F2543AQ28079455-EA79A2CF-DDF4-4814-A0C8-8EB47B67EA6EQ28080090-0FE414CB-F33D-44AD-A347-5F3183DCB722Q30248766-1DECA39B-892C-4127-A51D-FD204209489AQ30490742-751F4828-4FD3-4665-8CBC-DAD609E41DFAQ33654409-7C552B49-0307-4500-9763-566E7B66E236Q33893725-430C7B44-314A-4AA5-9F55-AACB71520243Q35819184-4EF5FBB2-C011-4658-8161-DF6FB6734E45Q36037844-DEC30778-306A-4CE7-8C18-820D43275B15Q36060923-00D047BD-E8F7-472B-8405-58FEDE7EA77FQ36361960-BE71CAF4-1D44-46AE-B265-3B107E1DE29FQ36515170-2F64F20F-0CAD-4638-BDE0-A9E3852AA7EDQ36523946-B6BA40D9-FB4A-4F0E-B002-5507ECA78885Q36525896-61C4617A-5EEB-453C-BAFA-344AF2AF1CA0Q36596027-FBC88E16-AA8B-4E3E-8FC8-4257CC5A4CACQ36617991-2ACB97C1-A37A-44F1-B53D-6DF62AA38C02Q36644877-5C22FD84-DCFE-4F82-9652-9AC8EB7B4FD2Q36734972-91F2B52F-EEF3-4F78-ADF1-6CFD77FE22BBQ36790027-3AACF2C6-6D18-43AA-8533-53B0496F91ABQ37034469-7538C8F8-3222-48B0-BDB7-D7EB4253F5C7Q37144949-3085416B-7BFC-4FEB-A76F-79B0DF7AFB5AQ37356604-D6A891ED-7726-4EB2-9DA9-753FC59ACDF9Q37505823-DA7291AB-55B2-402F-BE9A-AEED8F05F648Q37593171-8A8D9DAE-2F74-49B0-AC42-B2BBED9D5EDFQ37593177-F39D47A3-8AFF-4BEA-9565-750DE2B06175Q37627212-653B0CC7-3886-4553-8142-FA65EB5A1577Q37627236-0AA83981-A0DA-437C-8396-3A7693B50A10Q37656766-F6DFF6EA-8EE7-4D66-A1A0-212538E35245Q37661770-E2547364-4008-4755-80EB-FA260375F1B5Q38379102-5020ABDE-5CD6-4F53-8450-38A535CBA420Q38675631-372394FF-AD72-4BC9-9013-D1FF9EB575FFQ38682294-5C853928-A675-4A3B-85E2-0AB7C4DFB991Q38692205-4A5A3EAC-8FCC-441C-A041-47D2F9332488Q38751678-6A5DD8E0-D094-4E1F-8385-FB3BE380D321Q38773102-1D45FC24-17E1-4718-B8F5-28C1FFAEEBB8Q38800533-FAB7D212-A509-4790-9A4D-9E377EB06AFF
P2860
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
@ast
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
@en
type
label
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
@ast
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
@en
prefLabel
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
@ast
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
@en
P2093
P2860
P50
P1433
P1476
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
@en
P2093
Christel R Brinkmann
Giuseppe Pantaleo
Kersten K Koelsch
Maja Sommerfelt
Mette E Graversen
Remi Fromentin
William J Hey-Cunningham
P2860
P304
P356
10.1371/JOURNAL.PPAT.1005142
P50
P577
2015-09-17T00:00:00Z